Kozluca Hatice, Dural Emrah, Karabıyıkoğlu Gülseren, Söylemezoğlu Tülin
Department of Chest Diseases, Faculty of Medicine, Ankara University, Ankara, Turkey.
Department of Forensic Toxicology, Institute of Forensic Sciences, Ankara University, Ankara, Turkey.
Tuberk Toraks. 2018 Dec;66(4):317-324. doi: 10.5578/tt.66932.
Smoking is the leading cause of chronic obstructive pulmonary disease (COPD) and cotinine is reliable marker of tobacco exposure. We aimed to investigate the relationship between pulmonary function tests (FVC%, FEV1, FEV1/FVC and FEF25-75%), smoking history and blood cotinine levels in healthy volunteers as a control and patients who have COPD in our study.
One hundred and two COPD patients and 106 healthy volunteers who admitted to our institution were included. Spirometric investigations of the patients and volunteers were performed. A simple, rapid and reliable gas chromatography-mass spectrometry (GC-MS) method was used for determination of cotinine levels in blood samples.
The cut-off value of cotinine was determined as 41.12 ng/mL (97.2% sensitivity and 100% specificity). A significant relationship was observed between average pack-year and cotinine level in current smoker group (p< 0.05). The mean cotinine levels were 6.1, 8.8, and 467.0 ng mL-1 in never smokers, ex-smokers and current smokers, respectively. No relationship was observed between cotinine level and FVC%, FEV1% and FEV1/FVC (p> 0.05). In patient group, there was also no relationship between FEF25-75% and cotinine level however, in control group-smokers a negative correlation was found (p< 0.05; r= -0.372).
We observed once again with our study that cotinine is a reliable marker of tobacco exposure. The most obvious result is the negative correlation between FEF25-75% value and cotinine level and this result may be caused by the effect of smoking in the peripheral airways at early stages of COPD.
吸烟是慢性阻塞性肺疾病(COPD)的主要病因,可替宁是烟草暴露的可靠标志物。在我们的研究中,我们旨在调查健康志愿者(作为对照)和慢性阻塞性肺疾病患者的肺功能测试(用力肺活量百分比、第一秒用力呼气容积、第一秒用力呼气容积/用力肺活量和25%-75%用力呼气流量)、吸烟史与血中可替宁水平之间的关系。
纳入了102例慢性阻塞性肺疾病患者和106例入住我院的健康志愿者。对患者和志愿者进行了肺量计检查。采用一种简单、快速且可靠的气相色谱-质谱联用(GC-MS)方法测定血样中的可替宁水平。
可替宁的临界值确定为41.12 ng/mL(灵敏度为97.2%,特异性为100%)。在当前吸烟者组中,平均吸烟包年数与可替宁水平之间存在显著相关性(p<0.05)。从不吸烟者、既往吸烟者和当前吸烟者的平均可替宁水平分别为6.1、8.8和467.0 ng/mL。可替宁水平与用力肺活量百分比、第一秒用力呼气容积百分比和第一秒用力呼气容积/用力肺活量之间未观察到相关性(p>0.05)。在患者组中,25%-75%用力呼气流量与可替宁水平之间也无相关性,然而,在对照组吸烟者中发现存在负相关(p<0.05;r = -0.372)。
我们的研究再次观察到可替宁是烟草暴露的可靠标志物。最明显的结果是25%-75%用力呼气流量值与可替宁水平之间的负相关,这一结果可能是由于慢性阻塞性肺疾病早期吸烟对外周气道的影响所致。